Ostarine vs Cardarine: Key Differences Explained
Ostarine (MK-2866) is a selective androgen receptor modulator (SARM), whereas Cardarine (GW-501516) is a PPARδ agonist. They function through entirely different biological pathways.
What Was Ostarine Designed To Do?
- Developed by GTx, Inc.
- Intended for muscle wasting and cachexia management.
- Ostarine selectively binds to androgen receptors to promote muscle growth.
In practical terms, this means Ostarine helps increase muscle mass by specifically targeting receptors that are essential for muscle development, minimizing effects on other tissues.
Human clinical trials have been conducted to assess its effectiveness and safety profile.
What Was Cardarine Designed To Do?
- Developed by GlaxoSmithKline.
- Designed to activate PPARδ pathways for lipid metabolism and endurance research.
- Cardarine enhances energy utilization by influencing metabolic pathways.
In practical terms, this means Cardarine has the potential to boost endurance by optimizing how the body uses fat for energy.
However, its clinical development was discontinued.
Key Differences
| Aspect | Ostarine | Cardarine |
|---|---|---|
| Compound Class | SARM | PPARδ agonist |
| Developer | GTx, Inc. | GlaxoSmithKline |
| Mechanism | Androgen receptor targeting | Metabolic pathway activation |
| Clinical Progression | Human trials conducted | Development discontinued |
| Availability of Human Data | Available | Limited |
What Actually Separates Them?
Ostarine targets androgen receptors, crucial for muscle growth, while Cardarine targets metabolic pathways, influencing lipid metabolism and endurance. This distinction is fundamental as it shapes their uses and potential benefits.
Legal Considerations + Research Disclaimer
Due to their unique nature, these compounds are subject to legal restrictions and ongoing research. It is crucial to consult scientific literature and regulatory guidelines for the latest information.